Lipidem

Omega-3-Acid Triglycerides, the active ingredient in Lipidem, is a parenteral lipid emulsion presented as a sterile injectable solution for intravenous use. It provides essential fatty acids and calories to patients who cannot receive adequate nutrition enterally. GNH USA supplies Lipidem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lipidem is used in clinical situations that require parenteral delivery of calories and essential fatty acids. - Parenteral nutrition: supplies energy and essential fatty acids when oral or enteral feeding is insufficient. - Essential fatty acid deficiency: corrects deficiency in patients with prolonged limited enteral intake. - Preterm infants: supports growth and development when oral feeding is not yet possible.

Lipidem may be associated with several adverse reactions.

Common Side Effects: - Hypertriglyceridemia: elevated serum triglyceride levels after infusion. - Fever or chills: transient temperature rise during or shortly after administration. - Infusion site reactions: erythema, pain, or swelling at the catheter site. - Elevated liver enzymes: transient increase in ALT/AST. - Electrolyte disturbances: mild shifts in phosphate or calcium levels.

Serious or Rare Side Effects: - Fat overload syndrome: severe hyperlipidaemia with hepatic dysfunction. - Anaphylactic or severe allergic reactions: respiratory distress, hypotension, or rash. - Pulmonary embolism: rare occurrence of lipid emboli in the lungs. - Thrombocytopenia: significant drop in platelet count. - Severe hyperlipidaemia leading to pancreatitis. - Infection risk: contamination of the lipid emulsion can lead to sepsis.

When using Lipidem, clinicians should observe several safety measures. - Monitor triglyceride levels: check serum triglycerides regularly during therapy. - Assess liver function: perform periodic liver enzyme tests. - Evaluate for fat metabolism disorders: avoid in patients with known disorders of lipid metabolism. - Use caution in sepsis or coagulopathy: consider bleeding risk and inflammatory status. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lipidem can interact with other agents that affect lipid metabolism or coagulation.

Major Interactions (Avoid): - Concurrent lipid emulsions: may cause excess caloric and lipid load. - High‑dose propofol infusion: both provide lipids, increasing risk of fat overload. - Certain anticoagulants (e.g., warfarin): lipid infusion may alter plasma protein binding.

Moderate Interactions (Monitor Closely): - Systemic corticosteroids: can exacerbate hypertriglyceridaemia. - Diuretics: may intensify electrolyte shifts associated with lipid infusion. - Immunosuppressants (e.g., cyclosporine): increased infection susceptibility when combined with lipid emulsions.